Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers (Q46159400)

20 December 2017

title

Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers (English)

1 reference

20 December 2017

1 reference

Yoo-Kyung Lee

1

1 reference

20 December 2017

Noh-Hyun Park

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

15 January 2009

1 reference

20 December 2017

published in

Gynecologic Oncology

1 reference

20 December 2017

volume

112

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

475-480

1 reference

20 December 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Long-term results and prognostic factors in patients with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

P53 mutation does not affect prognosis in ovarian epithelial malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

PTEN mutations are common in sporadic microsatellite stable colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Epigenetic PTEN silencing in malignant melanomas without PTEN mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Loss of PTEN expression as a prognostic marker for tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Regulation of PTEN transcription by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

Distinct subtypes of serous ovarian carcinoma identified by p53 determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.031

10.1016/J.YGYNO.2008.11.031

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017